United States
Germany
Japan
United Kingdom
China
TLR8 mouse monoclonal antibody,clone OTI4F3
| Applications | IHC, WB |
| Reactivities | Human |
Products
TLR8 (Myc-DDK-tagged)-Human toll-like receptor 8 (TLR8)
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
TLR8 (tGFP-tagged) - Human toll-like receptor 8 (TLR8)
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
TLR8 mouse monoclonal antibody,clone OTI3A6
| Applications | WB |
| Reactivities | Human |
Purified recombinant protein of Human toll-like receptor 8 (TLR8), with C-terminal MYC/DDK tag, expressed in HEK293 cells, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293 |
Tlr8 (Myc-DDK-tagged) - Mouse toll-like receptor 8 (Tlr8)
| Type | Mouse Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
TLR8 mouse monoclonal antibody,clone OTI2F5
| Applications | WB |
| Reactivities | Human |
TLR8 mouse monoclonal antibody,clone OTI4F3
| Applications | IHC, WB |
| Reactivities | Human |
Lenti ORF clone of Human toll-like receptor 8 (TLR8), mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human toll-like receptor 8 (TLR8), Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK |
- LentiORF®
TLR8 mouse monoclonal antibody,clone OTI3A6
| Applications | WB |
| Reactivities | Human |
TLR8 mouse monoclonal antibody,clone OTI2F5
| Applications | WB |
| Reactivities | Human |
Purified recombinant protein of Human toll-like receptor 8 (TLR8), Arg32-Leu153, with N-terminal His-ABP tag, expressed in E.coli, 50ug
| Tag | N-His-ABP (Albumin-Binding Protein) |
| Expression Host | E. coli |
TLR8 (untagged)-Human toll-like receptor 8 (TLR8)
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
TLR8 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
